The healthcare market of Mexico has significant potential for growth. The increasing elderly population, the growing prevalence of non-communicable diseases, improvements in regulatory guidelines, government support for the healthcare sector, and the North American Free Trade Agreement, which assures its members protection of intellectual property rights, provide the impetus for growth.
Between 2015 and 2020, the market is forecast to increase from $19.4 billion to $29.4 billion, at a Compound Annual Growth Rate (CAGR) of 8.7%, owing to an improved and updated regulatory environment, a market with a broad population base, and government initiatives in the public healthcare sector.
The government has been successful in implementing the steps needed to achieve universal healthcare coverage, such as reforms in the System of Social Protection in Health (Sistema de Protección Social en Salud). In 2012, approximately 56 million people in Mexico were covered by Public Health Insurance (Seguro Popular, PHI). The rest of the population uses either social security coverage for healthcare or private healthcare insurance.
GlobalData’s latest report: “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Mexico is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Mexico. It identifies the key trends in the country’s healthcare market and provides insights into its healthcare infrastructure and demographic, regulatory and reimbursement landscape. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets.
Single User Price: $1,995